Growing community of inventors

Biberach an der Riss, Germany

Kenji Egusa

Average Co-Inventor Count = 5.33

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 81

Kenji EgusaThomas Friedl (4 patents)Kenji EgusaMichael Braun (4 patents)Kenji EgusaTakaaki Nishioka (4 patents)Kenji EgusaMegumi Maruyama (4 patents)Kenji EgusaHikaru Fujita (4 patents)Kenji EgusaMasanori Ito (3 patents)Kenji EgusaRoman Messerschmid (3 patents)Kenji EgusaPeter Schneider (3 patents)Kenji EgusaRemko Alexander Bakker (1 patent)Kenji EgusaKazutoshi Yokoyama (1 patent)Kenji EgusaTakuma Katayama (1 patent)Kenji EgusaNgai Hang Victor Chong (1 patent)Kenji EgusaJoerg Rippmann (1 patent)Kenji EgusaKyle Kleinbeck (1 patent)Kenji EgusaVenkata Voleti (1 patent)Kenji EgusaTakaaki Nishioka (0 patent)Kenji EgusaHikaru Fujita (0 patent)Kenji EgusaMegumi Maruyama (0 patent)Kenji EgusaKenji Egusa (8 patents)Thomas FriedlThomas Friedl (11 patents)Michael BraunMichael Braun (4 patents)Takaaki NishiokaTakaaki Nishioka (4 patents)Megumi MaruyamaMegumi Maruyama (4 patents)Hikaru FujitaHikaru Fujita (4 patents)Masanori ItoMasanori Ito (8 patents)Roman MesserschmidRoman Messerschmid (6 patents)Peter SchneiderPeter Schneider (4 patents)Remko Alexander BakkerRemko Alexander Bakker (8 patents)Kazutoshi YokoyamaKazutoshi Yokoyama (4 patents)Takuma KatayamaTakuma Katayama (1 patent)Ngai Hang Victor ChongNgai Hang Victor Chong (1 patent)Joerg RippmannJoerg Rippmann (1 patent)Kyle KleinbeckKyle Kleinbeck (1 patent)Venkata VoletiVenkata Voleti (1 patent)Takaaki NishiokaTakaaki Nishioka (0 patent)Hikaru FujitaHikaru Fujita (0 patent)Megumi MaruyamaMegumi Maruyama (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Boehringer Ingelheim International Gmbh (8 from 1,537 patents)


8 patents:

1. 11564886 - Pharmaceutical compositions

2. 10973827 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation

3. 10603292 - Pharmaceutical composition and pharmaceutical dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof

4. 10596120 - Pharmaceutical compositions

5. 10022379 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation

6. 9555001 - Pharmaceutical composition and uses thereof

7. 9415016 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation

8. 9155705 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…